Thursday, April 21 Scientific Platform Sessions 6:30 a.m.–8:30 a.m. Scientific Platform Sessions S44: Developments in Peripheral Neuropathies 6:30 a.m. S44.001 The Diagnostic Performance and Clinical Relevance of Corneal Confocal Microscopy (CCM) in Patients with Diabetic Peripheral Neuropathy —A. Gordon Smith, Gabriel Kowalsky, Peter Hauer, Adrienne Aperghis, J. Singleton 6:45 a.m. S44.002 Identification of ALS5/SPG11/KIAA1840 Mutations in Patients with Autosomal Recessive Form of Charcot-Marie-Tooth Disease Type 2 —Celeste Montecchiani, Lucia Pedace, Temistocle Lo Giudice, Antonella Casella, Marzia Mearini, Fabrizio Gaudiello, Jose Luiz Pedroso, Chiara Terracciano, Carlo Caltagirone, Roberto Massa, Peter St George-Hyslop, Orlando Barsottini, Toshitaka Kawarai, Antonio Orlacchio 7:00 a.m. S44.003 New Molecules for an Irreversible Disorder: MRNAs and MiRNAs in Experimental Diabetic Neuropathy — Douglas Zochodne, Chu Cheng, Masaki Kobayashi 7:15 a.m. S44.004 The Marriage of High-Resolution Sonography and Nerve Conduction Studies in IgM MGUS Polyneuropathy: More Generalised Than Length Dependent? —Stephan Goedee, Nicolette Notermans, Ludo Van Der Pol, Hessel Franssen, Jan-Thies Van Asseldonk, Leendert Visser, Leonard Van den Berg 7:30 a.m. S44.005 Three-Dimensional Study of Neuromuscular Junctions (NMJ) in Heterozygous R98C Knock-in CMT1B Mouse Model by Overexpression Neuregulin 1 Type III —Yunhong Bai, Chiara Pisciotta, Suola Wang, Xingyao Wu, Markus H Schwab, Klaus Armin Nave, Michael Shy 7:45 a.m. S44.006 Characterization of Pain in a Large Cohort of Patients with Charcot-Marie- Tooth Diseases —Derek Huang, Michael Shy, Callyn Kirk, Christopher Lee, Jun Li 8:00 a.m. S44.007 Evaluation of Sarm1 Gene Deletion in a Mouse Model of Vincristine-Induced Neuropathy —Stefanie Geisler, Ryan Doan, Amy Strickland, Huang Xin, Jeffrey Milbrandt, Aaron DiAntonio 8:15 a.m. S44.008 Target-Enrichment Sequencing and Copy Number Evaluation in Inherited Polyneuropathy —Christopher Klein, Wei Wang, Chen Wang, Brian Dawson, Thorland Erik, Patrick Lundquist, Bruce Eckloff, Yanhong Wu, Saurabh Baheti, Jared Evans, Steven Scherer, Peter Dyck S45: MRI and OCT Outcomes in Multiple Sclerosis 6:30 a.m. S45.001 Thalamic Atrophy As Primary Endpoint for Phase 2 Trials in MS: Sample Size Calculations —Christina Azevedo, Daniel Pelletier 6:45 a.m. S45.002 The Baseline MRI Scan in Clinically Isolated Syndromes: Predictors of Disability After 15 Years —Wallace Brownlee, Daniel Altmann, Claudia Wheeler-Kingshott, Katherine Miszkiel, Olga Ciccarelli, David Miller 7:00 a.m. S45.003 Comparison of MRI Criteria for the Diagnosis of Multiple Sclerosis: Role of Cortical Lesions —Paolo Preziosa, Maria Rocca, Sarlota Mesaros, Massimiliano Copetti, Alex Rovira, Jaume Sastre Garriga, Jelena Drulovic, Amgad Droby, Frauke Zipp, Massimiliano Calabrese, Massimo Filippi 7:15 a.m. S45.004 INSPIRATION-MRI: Standardized Acquisition and Centralized Quantitative Reading of MRI Scans of RRMS Patients in German Daily Clinical Practice —Achim Gass, Johannes Gregori, Stefan Hoffmann, Alexander Fuchs, Christian Cornelissen 7:30 a.m. S45.005 Neurological Software Tool for REliable Atrophy Measurement (NeuroSTREAM) in Multiple Sclerosis —Michael Dwyer, Diego Silva, Niels Bergsland, Dana Horakova, Deepa Ramasamy, Jackie Durfee, Manuela Vaneckova, Eva Havrdova, Robert Zivadinov 7:45 a.m. S45.006 A Comparison of Two Methods for Quantifying Blood-Brain Barrier Disruption, with Application to Multiple Sclerosis —Nolan Chen, Kartiga Selvaganesan, Daniel Reich, Govind Nair, Richard Leigh 8:00 a.m. S45.007 Retinal Atrophy Measured by Optical Coherence Tomography Predicts Disability Progression in Multiple Sclerosis —Elena Martinez-Lapiscina, Samuel Arnow, James Wilson, Shiv Saidha, Jana Preiningerova, Timm Oberwahrenbrock, Alexander Brandt, Luis E Pablo, Simone Guerrieri, Ines Gonzalez, Olivier Outteryck, Ann-Kristin Mueller, Phillip Albrecht, Wesley Chan, Sebastian Lukas, Lisanne Balk, Clare Fraser, Jette Lautrup Frederiksen Battisti, Jennifer Resto, Teresa Frohman, Christian Cordano, Irati Zubizarreta, Bernardo Sanchez- Dalmau, Albert Saiz, Robert Bermel, Alexander Klistoner, Axel Petzold, Sven Schippling, Fiona Costello, Orhan Aktas, Patrick Vermersch, Celia Oreja-Guevara, Giancarlo Comi, Letizia Leocani, Elena Garcia-Martin, Friedemann Paul, Eva Havrdova, Elliot Frohman, Laura Balcer, Ari Green, Peter Calabresi, Pablo Villoslada 8:15 a.m. S45.008 Disease Modifying Therapies Modulate Retinal Atrophy in Multiple Sclerosis: A Retrospective Study —Julia Button, Omar Al-Louzi, Andrew Lang, Pavan Bhargava, Scott Newsome, Laura Balcer, Elliot Frohman, Jerry Prince, Peter Calabresi, Shiv Saidha S46: Critical Care 6:30 a.m. S46.001 Sulfonylurea Receptor-1 As a Novel Biomarker for Cerebral Edema in Patients with Severe Traumatic Brain Injury —Ruchira Jha, Ava Puccio, Sherry Chou, Chung-Chou Chang, Jessica Wallisch, Bradley Molyneaux, Benjamin Zusman, Lori Shutter, Samuel Poloyac, Janesko-Feldman Keri, David Okonkwo, Patrick Kochanek 6:45 a.m. S46.002 Thermoregulatory Variability Is an Independent Predictor of Death or Poor Outcome After Brain Injury: A Cohort Study —Varoon Thavapalan, Fred Rincon 7:00 a.m. S46.003 Factors Considered by Physicians Versus Nurses When Prognosticating Acute Intracerebral Hemorrhage Outcomes —David Hwang, Stacy Chu, Cameron Dell, Mary Sparks, Tiffany Watson, Carl Langefeld, Mary Comeau, Jonathan Rosand, Thomas Battey, Sebastian Koch, Mario Perez, Michael James, Jessica McFarlin, Jennifer Osborne, Daniel Woo, Steven Kittner, Kevin Sheth 7:15 a.m. S46.004 Utility of Brain MRI in Infective Endocarditis —Tia Chakraborty, Eugene Scharf, Daniel DeSimone, El-Rafei Abdelghani, Alejandro Rabinstein, Eelco Wijdicks, Larry Baddour, Jennifer Fugate 7:30 a.m. S46.005 Observations of Paradoxical ICP Patterns Within 24 Hours Preceding Neurovascular Related Mortality —Paul Sampognaro, Nirav Shah, Wade Smith, Xiao Hu 7:45 a.m. S46.006 Neurointensivist Prognostication Aids Decision Making in Anoxic Brain Injury Patients —Neha Prakash, Joanna Ramiro, Eliahu Feen, Abhay Kumar 8:00 a.m. S46.007 ApoE E3 Allele and DRS Outcome in Patients with Severe Traumatic Brain Injury (TBI)—Lucido Ponce Mejia, Jovany Cruz Navarro, Goodman Jerry, Claudia Robertson 8:15 a.m. S46.008 Prognostic Value of the Neurological Exam in Cardiac Arrest Patients Treated with Therapeutic Hypothermia —Elizabeth Matthews, Jessica Magid-Bernstein, Angela Velazquez, Christina Falo, Soojin Park, Jan Claassen, Sachin Agarwal Plan Your Annual Meeting Experience with Convenient Online Program Search Planning your Annual Meeting week just got easier! Gain insight with helpful tips and suggested programs that may be of most interest to you—and applicable to your career. AAN.com/view/SearchAM 132 2016 AAN Annual Meeting Abstract Listing
Meeting Schedule 6:30 a.m.–8:30 a.m. S44 Developments in Peripheral Neuropathies S45 MRI and OCT Outcomes in Multiple Sclerosis S46 Critical Care C202 S The Eyes and The Ears of Traumatic Brain Injury Director: Laura J. Balcer, MD, MSCE, FAAN, New York, NY C203 Vascular Cognitive Impairment and Dementia: Current Status and Future Director: Larry B. Goldstein, MD, FAAN, FAHA, Lexington, KY C204 Important Drug Interactions for Neurologists and Psychiatrists Director: Laurence J. Kinsella, MD, FAAN, St. Louis, MO C205 Cerebellar and Afferent Ataxias: Diagnosis and Management Director: Massimo Pandolfo, MD, FAAN, Brussels, Belgium C206 Neuro Flash: MRI and Multiple Sclerosis Director: Robert T. Naismith, MD, St. Louis, MO C207 Stroke in Young Adults and Women Director: Aneesh B. Singhal, MD, FAAN, Boston, MA C208 Approach to Sleep Symptoms: Sleepy or Sleepless Director: Raman K. Malhotra, MD, St. Louis, MO C209 What Neurologists Really Need to Know About Normal Pressure Hydrocephalus Director: Michael A. Williams, MD, FAAN, Seattle, WA C210 Non-Neuro-oncology Palliative Care Director: Maisha T. Robinson, MD, MS, Jacksonville, FL C211 Emergency Room Neuro-ophthalmology Director: Heather Moss, MD, PhD, Chicago, IL C212 Overview of Parkinson’s Disease Director: Melissa J. Nirenberg, MD, PhD, FAAN, New York, NY 8:00 a.m.–9:00 a.m. I It’s a Bird, It’s a Plane, It’s...The Doctor Who Cured My Benign Paroxysmal Positional Vertigo Director: Kevin A. Kerber, MD, Ann Arbor, MI 8:30 a.m.–5:30 p.m. P6 Poster Session VI 9:00 a.m.–11:30 a.m. Neurology Year in Review Plenary Session . . .143 11:00 a.m.–3:00 p.m. Exhibit Hall 1:00 p.m.–1:30 p.m. Health & Wellness The Role of Exercise in Treatment of Peripheral Neuropathy Director: A. Gordon Smith, MD, FAAN, Salt Lake City, UT $ A registration fee is required L The program is one of the AAN Leadership University sessions S The course is part of a Subspecialty in Focus track I The program is one of the I Talk sessions Learning Lab The program is part of the Excitement of Discovery Experiential Learning Area Health & Wellness sessions Real World of Neurology Thu · April 21 Fast and easy registration · AAN.com/view/AM16 133
Change language